UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Strategy Inc
MSTR
|
+$745M |
| 3 |
EA
Electronic Arts
EA
|
+$725M |
| 4 |
TotalEnergies
TTE
|
+$639M |
| 5 |
Walmart Inc
WMT
|
+$585M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.87B |
| 2 |
Apple
AAPL
|
+$1.41B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 5 |
Southwest Airlines
LUV
|
+$727M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.52% |
| 2 | Financials | 9.54% |
| 3 | Healthcare | 6.68% |
| 4 | Industrials | 6.61% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4951
CALL
ACM Research
ACMR
$5.65B
| $2M | ﹤0.01% |
50,700
| – | – |
|
|
CCRP
4952
Columbia Corporate Bond ETF
CCRP
$52.4M
| $2M | ﹤0.01% |
+100,000
| New | +$2M |
|
|
CSR
4953
Centerspace
CSR
$939M
| $1.99M | ﹤0.01% |
29,878
-66,627
| -69% | -$4.19M |
|
4954
GSI Technology
GSIT
$260M
| $1.99M | ﹤0.01% |
320,672
+153,000
| +91% | +$1.09M |
|
4955
Rigel Pharmaceuticals
RIGL
$762M
| $1.99M | ﹤0.01% |
46,438
-54,159
| -54% | -$2.04M |
|
|
HIO
4956
Western Asset High Income Opportunity Fund
HIO
$338M
| $1.98M | ﹤0.01% |
534,544
-218,646
| -29% | -$828K |
|
4957
Quanterix
QTRX
$135M
| $1.98M | ﹤0.01% |
311,499
-62,101
| -17% | -$386K |
|
4958
Columbia India Consumer ETF
INCO
$239M
| $1.98M | ﹤0.01% |
30,555
+10,119
| +50% | +$657K |
|
4959
Arvinas
ARVN
$589M
| $1.98M | ﹤0.01% |
166,917
-233,219
| -58% | -$2.55M |
|
4960
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$263M
| $1.98M | ﹤0.01% |
15,094
+1,326
| +10% | +$172K |
|
4961
Enlight Renewable Energy
ENLT
$12B
| $1.98M | ﹤0.01% |
43,526
+38,657
| +794% | +$1.44M |
|
4962
Keros Therapeutics
KROS
$211M
| $1.98M | ﹤0.01% |
97,084
-6,780
| -7% | -$119K |
|
4963
TaskUs
TASK
$667M
| $1.98M | ﹤0.01% |
167,528
+134,077
| +401% | +$1.71M |
|
4964
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$796M
| $1.97M | ﹤0.01% |
61,968
-20,500
| -25% | -$637K |
|
|
ITIC
4965
Investors Title Co
ITIC
$534M
| $1.97M | ﹤0.01% |
7,904
+1,076
| +16% | +$283K |
|
4966
Global X MSCI Argentina ETF
ARGT
$809M
| $1.96M | ﹤0.01% |
21,407
-114,112
| -84% | -$9.74M |
|
4967
PUT
Align Technology
ALGN
$12.5B
| $1.95M | ﹤0.01% |
+12,500
| New | +$1.79M |
|
4968
Equity Bancshares
EQBK
$1.07B
| $1.95M | ﹤0.01% |
43,698
+1,719
| +4% | +$73.5K |
|
4969
Fossil Group
FOSL
$330M
| $1.95M | ﹤0.01% |
518,790
-42,795
| -8% | -$121K |
|
4970
Alerian Energy Infrastructure ETF
ENFR
$519M
| $1.95M | ﹤0.01% |
61,975
+7,670
| +14% | +$238K |
|
4971
Origin Bancorp
OBK
$1.69B
| $1.95M | ﹤0.01% |
51,783
-19,750
| -28% | -$708K |
|
4972
Castellum
CTM
$62.4M
| $1.95M | ﹤0.01% |
2,155,157
+2,133,376
| +9,795% | +$2.28M |
|
4973
Vuzix
VUZI
$220M
| $1.94M | ﹤0.01% |
513,434
+266,712
| +108% | +$838K |
|
4974
CALL
Trade Desk
TTD
$6.84B
| $1.94M | ﹤0.01% |
51,100
+20,000
| +64% | +$887K |
|
4975
Fidelity Enhanced Small Cap Core ETF
FESM
$6.35B
| $1.94M | ﹤0.01% |
51,316
+37,259
| +265% | +$1.39M |
|
Similar funds
UBS Group's Q4 2025 Portfolio in Review
As of Q4 2025, UBS Group held 11,616 positions worth $617B, down 3.4% from $638B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $32.7B in Q4 2025, closing 1,184 positions and reducing 4,502 holdings. Its most notable exit was Kellanova, an estimated $617M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Solstice Advanced Materials worth $130M.
- UBS Group's largest Q4 2025 buy was Solstice Advanced Materials: 2,681,543 shares worth $130M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $1.26B increase.
- UBS Group's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.87B.
- UBS Group fully exited Kellanova in Q4 2025, selling an estimated $617M.
- UBS Group's ten largest holdings make up 15% of its $617B portfolio in Q4 2025.
- UBS Group opened 1,319 new positions and closed 1,184 in Q4 2025.
- UBS Group's portfolio value fell 3.4% quarter-over-quarter to $617B.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.